AI Summary & Key Takeaways
AI InsightResults: The overall incidence of glaucoma after PKP was 11.6% (102 eyes).
📌 3 Key Takeaways
Abstract
Purpose: To evaluate the effects of glaucoma and its therapy on graft survival after penet-rating keratoplasty. Material and methods: Eight hundred and seventy-six penetrating keratoplasty (PKP) cases were evaluated retrospectively. The effects of glaucoma and its therapy on immune reaction and graft survival were investigated with a mean follow up of 28.3 months. Results: The overall incidence of glaucoma after PKP was 11.6% (102 eyes). Of the glaucoma patients, 53 (52%) were treated medically and 49 (42%) necessitated surgical treatment.2.9 (59.2%) eyes required additional topical antiglaucoma medications after glaucoma surgery. Immune reactions had similar incidence in patients with and without glaucoma. But, the rate of graft failure after immune reactions was higher in patients with glaucoma (66.6%) than in those without glaucoma (19.4%) (p
Özet
Amaç: Penetran keratoplasti sonrası glokom ve tedavisinin greft canlılığı üzerine etkisini araştırmak. Materyal ve metod: Sekiz yüz yetmiş altı penetran keratoplasti (PKP) retrospektif olarak incelendi. Ortalama 28.3 aylık takiple glokom ve tedavisinin, imnıün reaksiyon ve greft canlılığı üzerine etkisi araştırıldı. Bulgular: PKP sonrası glokomun ortalama sıklığı %11.6'idi (102 göz). Glokomlu hastaların 53'ü (%52) medikal olarak tedavi edildi, 49'una (%48) cerrahi tedaviye ihtiyaç duyuldu. 29 göze (%59.2) glokom cerrahisi sonrası ilave topikal antiglokomatöz medikasyon gerekti. İm-mün reaksiyon glokomlu ve glokomsuz gözlerde benzer orandaydı. Fakat immün reaksiyon sonrası greft başarısızlığı, glokomlu (%66.6) gözlerde glokomsuz gözlere (%19.4) göre daha yüksekti (p